Plerixafor Injection, Solution
Product Images NDC 68083-155

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Plerixafor (NDC 68083-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Plerixafor-spl-carton (Plerixafor Spl Carton)

This is a description of Plerixafor Injection, a medication used for subcutaneous injection. It comes in single-dose vials containing 24mg of Plerixafor in 1.2mL solution (20 mg/mL). The solution includes sodium chloride and is adjusted to a pH of 8.0-7.5 with hydrochloric acid and sodium hydroxide. The medication does not contain preservatives and should be stored at controlled room temperature. Be sure to follow the dosage and administration instructions provided in the package insert. The manufacturer is Gland Pharma Limited in India.*

FDA Label Image

Plerixafor-spl-container (Plerixafor Spl Container)

This is a prescription medication called Plerixafor Injection with a concentration of 24 mg per 1.2 mL (20 mg/mL). It is intended for subcutaneous injection as a single dose. The product is provided in a 1.2 mL single-dose vial manufactured by Gland Pharma Limited in India. The National Drug Code (NDC) is 68083-155-01. The US address of the manufacturer is also mentioned on the packaging. Note the details on the barcode and an unvarnished area of 11x18 mm.*

FDA Label Image

Plerixafor-spl-structure (Plerixafor Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.